A study to evaluate the effect of famciclovir in reducing herpes virus shedding.

Trial Profile

A study to evaluate the effect of famciclovir in reducing herpes virus shedding.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 26 Apr 2012

At a glance

  • Drugs Famciclovir (Primary)
  • Indications Herpes genitalis
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 26 Apr 2012 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
    • 28 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top